To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection
Dominika Šťastná, Ingrid Menkyová, Jiří Drahota, Tereza Hrnčiarová, Eva Havrdová, Marta Vachová, Michaela Andělová, Pavlína Kleinová, Ivana Kovářová, Eva Krasulová, Jana Lízrová Preiningerová, Iveta Nováková, Klára Novotná, Martina Novotná, Petra Nytrová, Jana Pavlíčková, Barbora Srpová, Katerina Storey, Veronika Tichá, Michaela Týblová, Tomáš Uher, Karolína Vodehnalová, Dana Horáková
Topics & Concepts
MedicineVaccinationMultiple sclerosisInternal medicineRetrospective cohort studyExacerbationCohortNeuromyelitis opticaYoung adultCoronavirus disease 2019 (COVID-19)PediatricsImmunologyDiseaseInfectious disease (medical specialty)Multiple Sclerosis Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research